IDEAS home Printed from https://ideas.repec.org/a/bla/jorssa/v169y2006i1p5-35.html
   My bibliography  Save this article

Multiparameter evidence synthesis in epidemiology and medical decision‐making: current approaches

Author

Listed:
  • A. E. Ades
  • A. J. Sutton

Abstract

Summary. Alongside the development of meta‐analysis as a tool for summarizing research literature, there is renewed interest in broader forms of quantitative synthesis that are aimed at combining evidence from different study designs or evidence on multiple parameters. These have been proposed under various headings: the confidence profile method, cross‐design synthesis, hierarchical models and generalized evidence synthesis. Models that are used in health technology assessment are also referred to as representing a synthesis of evidence in a mathematical structure. Here we review alternative approaches to statistical evidence synthesis, and their implications for epidemiology and medical decision‐making. The methods include hierarchical models, models informed by evidence on different functions of several parameters and models incorporating both of these features. The need to check for consistency of evidence when using these powerful methods is emphasized. We develop a rationale for evidence synthesis that is based on Bayesian decision modelling and expected value of information theory, which stresses not only the need for a lack of bias in estimates of treatment effects but also a lack of bias in assessments of uncertainty. The increasing reliance of governmental bodies like the UK National Institute for Clinical Excellence on complex evidence synthesis in decision modelling is discussed.

Suggested Citation

  • A. E. Ades & A. J. Sutton, 2006. "Multiparameter evidence synthesis in epidemiology and medical decision‐making: current approaches," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 169(1), pages 5-35, January.
  • Handle: RePEc:bla:jorssa:v:169:y:2006:i:1:p:5-35
    DOI: 10.1111/j.1467-985X.2005.00377.x
    as

    Download full text from publisher

    File URL: https://doi.org/10.1111/j.1467-985X.2005.00377.x
    Download Restriction: no

    File URL: https://libkey.io/10.1111/j.1467-985X.2005.00377.x?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Palmer, Stephen & Smith, Peter C., 2000. "Incorporating option values into the economic evaluation of health care technologies," Journal of Health Economics, Elsevier, vol. 19(5), pages 755-766, September.
    2. Sander Greenland, 2005. "Multiple‐bias modelling for analysis of observational data," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 168(2), pages 267-306, March.
    3. Tomasz Burzykowski & Geert Molenberghs & Marc Buyse, 2004. "The validation of surrogate end points by using data from randomized clinical trials: a case‐study in advanced colorectal cancer," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 167(1), pages 103-124, February.
    4. A. E. Ades & S. Cliffe, 2002. "Markov Chain Monte Carlo Estimation of a Multiparameter Decision Model: Consistency of Evidence and the Accurate Assessment of Uncertainty," Medical Decision Making, , vol. 22(4), pages 359-371, August.
    5. James C. Felli & Gordon B. Hazen, 1999. "A Bayesian approach to sensitivity analysis," Health Economics, John Wiley & Sons, Ltd., vol. 8(3), pages 263-268, May.
    6. Nicola J. Cooper & Keith R. Abrams & Alex J. Sutton & David Turner & Paul C. Lambert, 2003. "A Bayesian approach to Markov modelling in cost‐effectiveness analyses: application to taxane use in advanced breast cancer," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 166(3), pages 389-405, October.
    7. David J. Vanness & W. Ray Kim, 2002. "Bayesian estimation, simulation and uncertainty analysis: the cost‐effectiveness of ganciclovir prophylaxis in liver transplantation," Health Economics, John Wiley & Sons, Ltd., vol. 11(6), pages 551-566, September.
    8. A. E. Ades & G. Lu & K. Claxton, 2004. "Expected Value of Sample Information Calculations in Medical Decision Modeling," Medical Decision Making, , vol. 24(2), pages 207-227, March.
    9. Marc C. Kennedy & Anthony O'Hagan, 2001. "Bayesian calibration of computer models," Journal of the Royal Statistical Society Series B, Royal Statistical Society, vol. 63(3), pages 425-464.
    10. Karl Claxton & John Posnett, "undated". "An Economic Approach to Clinical Trial Design and Research Priority Setting," Discussion Papers 96/19, Department of Economics, University of York.
    11. N. J. Welton & A. E. Ades, 2005. "A model of toxoplasmosis incidence in the UK: evidence synthesis and consistency of evidence," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 54(2), pages 385-404, April.
    12. A. E. Ades & G. Lu, 2003. "Correlations Between Parameters in Risk Models: Estimation and Propagation of Uncertainty by Markov Chain Monte Carlo," Risk Analysis, John Wiley & Sons, vol. 23(6), pages 1165-1172, December.
    13. Andrew H. Briggs, 1999. "A Bayesian approach to stochastic cost‐effectiveness analysis," Health Economics, John Wiley & Sons, Ltd., vol. 8(3), pages 257-261, May.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Christine Godfrey, 2006. "Evidence-Based Illicit Drug Policy: The Potential Contribution of Economic Evaluation Techniques," De Economist, Springer, vol. 154(4), pages 563-580, December.
    2. Dungang Liu & Regina Y. Liu & Minge Xie, 2015. "Multivariate Meta-Analysis of Heterogeneous Studies Using Only Summary Statistics: Efficiency and Robustness," Journal of the American Statistical Association, Taylor & Francis Journals, vol. 110(509), pages 326-340, March.
    3. Woertman, Willem & Vermeulen, Bram & Groenewoud, Hans & van der Wilt, Gert Jan, 2013. "Evidence based policy decisions through a Bayesian approach: The case of a statin appraisal in the Netherlands," Health Policy, Elsevier, vol. 112(3), pages 234-240.
    4. David Lunn & Jessica Barrett & Michael Sweeting & Simon Thompson, 2013. "Fully Bayesian hierarchical modelling in two stages, with application to meta-analysis," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 62(4), pages 551-572, August.
    5. A. M. Presanis & D. De Angelis & D. J. Spiegelhalter & S. Seaman & A. Goubar & A. E. Ades, 2008. "Conflicting evidence in a Bayesian synthesis of surveillance data to estimate human immunodeficiency virus prevalence," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 171(4), pages 915-937, October.
    6. Isabelle Albert & Emmanuelle Espié & Henriette de Valk & Jean‐Baptiste Denis, 2011. "A Bayesian Evidence Synthesis for Estimating Campylobacteriosis Prevalence," Risk Analysis, John Wiley & Sons, vol. 31(7), pages 1141-1155, July.
    7. Lois G. Kim & Simon G. Thompson, 2010. "Uncertainty and validation of health economic decision models," Health Economics, John Wiley & Sons, Ltd., vol. 19(1), pages 43-55, January.
    8. Rebecca M. Turner & David J. Spiegelhalter & Gordon C. S. Smith & Simon G. Thompson, 2009. "Bias modelling in evidence synthesis," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 172(1), pages 21-47, January.
    9. C Elizabeth McCarron & Eleanor M Pullenayegum & Lehana Thabane & Ron Goeree & Jean-Eric Tarride, 2011. "Bayesian Hierarchical Models Combining Different Study Types and Adjusting for Covariate Imbalances: A Simulation Study to Assess Model Performance," PLOS ONE, Public Library of Science, vol. 6(10), pages 1-7, October.
    10. Patricia Guyot & Anthony E. Ades & Matthew Beasley & Béranger Lueza & Jean-Pierre Pignon & Nicky J. Welton, 2017. "Extrapolation of Survival Curves from Cancer Trials Using External Information," Medical Decision Making, , vol. 37(4), pages 353-366, May.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. A. E. Ades & Karl Claxton & Mark Sculpher, 2006. "Evidence synthesis, parameter correlation and probabilistic sensitivity analysis," Health Economics, John Wiley & Sons, Ltd., vol. 15(4), pages 373-381, April.
    2. Karl Claxton & Mark Sculpher & Chris McCabe & Andrew Briggs & Ron Akehurst & Martin Buxton & John Brazier & Tony O'Hagan, 2005. "Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra," Health Economics, John Wiley & Sons, Ltd., vol. 14(4), pages 339-347, April.
    3. A. Goubar & A. E. Ades & D. De Angelis & C. A. McGarrigle & C. H. Mercer & P. A. Tookey & K. Fenton & O. N. Gill, 2008. "Estimates of human immunodeficiency virus prevalence and proportion diagnosed based on Bayesian multiparameter synthesis of surveillance data," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 171(3), pages 541-580, June.
    4. Stefano Conti & Karl Claxton, 2008. "Dimensions of design space: a decision-theoretic approach to optimal research design," Working Papers 038cherp, Centre for Health Economics, University of York.
    5. Elisabeth Fenwick & Karl Claxton & Mark Sculpher, 2001. "Representing uncertainty: the role of cost‐effectiveness acceptability curves," Health Economics, John Wiley & Sons, Ltd., vol. 10(8), pages 779-787, December.
    6. Karnon, Jonathan, 2002. "Planning the efficient allocation of research funds: an adapted application of a non-parametric Bayesian value of information analysis," Health Policy, Elsevier, vol. 61(3), pages 329-347, September.
    7. N. J. Welton & A. E. Ades & D. M. Caldwell & T. J. Peters, 2008. "Research prioritization based on expected value of partial perfect information: a case‐study on interventions to increase uptake of breast cancer screening," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 171(4), pages 807-841, October.
    8. Karl Claxton & Elisabeth Fenwick & Mark J. Sculpher, 2012. "Decision-making with Uncertainty: The Value of Information," Chapters, in: Andrew M. Jones (ed.), The Elgar Companion to Health Economics, Second Edition, chapter 51, Edward Elgar Publishing.
    9. Rachael L. Fleurence, 2007. "Setting priorities for research: a practical application of 'payback' and expected value of information," Health Economics, John Wiley & Sons, Ltd., vol. 16(12), pages 1345-1357.
    10. S. Dias & N. J. Welton & V. C. C. Marinho & G. Salanti & J. P. T. Higgins & A. E. Ades, 2010. "Estimation and adjustment of bias in randomized evidence by using mixed treatment comparison meta‐analysis," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 173(3), pages 613-629, July.
    11. Jonathan Karnon, 2003. "Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation," Health Economics, John Wiley & Sons, Ltd., vol. 12(10), pages 837-848, October.
    12. Oakley, Jeremy E. & Brennan, Alan & Tappenden, Paul & Chilcott, Jim, 2010. "Simulation sample sizes for Monte Carlo partial EVPI calculations," Journal of Health Economics, Elsevier, vol. 29(3), pages 468-477, May.
    13. Eric Jutkowitz & Fernando Alarid-Escudero & Hyon K. Choi & Karen M. Kuntz & Hawre Jalal, 2017. "Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis," PharmacoEconomics, Springer, vol. 35(10), pages 1073-1085, October.
    14. Doug Coyle & Jeremy Oakley, 2008. "Estimating the expected value of partial perfect information: a review of methods," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 9(3), pages 251-259, August.
    15. N. J. Welton & A. E. Ades & J. B. Carlin & D. G. Altman & J. A. C. Sterne, 2009. "Models for potentially biased evidence in meta‐analysis using empirically based priors," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 172(1), pages 119-136, January.
    16. K. Claxton & P. J. Neumannn & S. S. Araki & M. C. Weinstein, "undated". "Bayesian Value-of-Information Analysis: An Application to a Policy Model of Alzheimer's Disease," Discussion Papers 00/39, Department of Economics, University of York.
    17. Andrea Manca & Nigel Rice & Mark J. Sculpher & Andrew H. Briggs, 2005. "Assessing generalisability by location in trial‐based cost‐effectiveness analysis: the use of multilevel models," Health Economics, John Wiley & Sons, Ltd., vol. 14(5), pages 471-485, May.
    18. Bas Groot Koerkamp & M. G. Myriam Hunink & Theo Stijnen & Milton C. Weinstein, 2006. "Identifying key parameters in cost‐effectiveness analysis using value of information: a comparison of methods," Health Economics, John Wiley & Sons, Ltd., vol. 15(4), pages 383-392, April.
    19. Daniele Bregantini, 2014. "Don’t Stop ’Til You Get Enough: a quickest detection approach to HTA," Discussion Papers 14/04, Department of Economics, University of York.
    20. Hawre Jalal & Jeremy D. Goldhaber-Fiebert & Karen M. Kuntz, 2015. "Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression Metamodeling," Medical Decision Making, , vol. 35(5), pages 584-595, July.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bla:jorssa:v:169:y:2006:i:1:p:5-35. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: https://edirc.repec.org/data/rssssea.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.